Trevena Inc (OTCPK:TRVN)

$ 1.61 -0.19 (-10.56%) Market Cap: 1.39 Mil Enterprise Value: 25.49 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q3 2023 Trevena Inc Earnings Call Transcript
Nov 14, 2023

$14.81 (-1.12%)

Earnings
Trevena Inc Business Update Transcript
Sep 06, 2023
Trevena Inc at H.C. Wainwright Neuropsychiatry Virtual Conference Transcript
Jun 26, 2023
Q1 2023 Trevena Inc Earnings Call Transcript
May 15, 2023

$29.5 (-12.59%)

Earnings
Q4 2022 Trevena Inc Earnings Call Transcript
Mar 30, 2023

$17.5 (-4.12%)

Earnings
Q3 2022 Trevena Inc Earnings Call Transcript
Nov 09, 2022

$76.31 (-30.74%)

Earnings
Q2 2022 Trevena Inc Earnings Call Transcript
Aug 11, 2022

$151.06 (+0.71%)

Earnings
Trevena Inc at JMP Securities Life Sciences Conference Transcript
Jun 15, 2022
Q1 2022 Trevena Inc Earnings Call Transcript
May 11, 2022

$122.38 (-31.82%)

Earnings
Q4 2021 Trevena Inc Earnings Call Transcript
Mar 31, 2022

$343.69 (+24.64%)

Earnings
Q3 2021 Trevena Inc Earnings Call Transcript
Nov 15, 2021

$531.25 (-9.09%)

Earnings
Trevena Inc TRV027 Proof-of-Concept Data Presentation Call Transcript
Sep 30, 2021
Trevena Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Sep 21, 2021
Q2 2021 Trevena Inc Earnings Call Transcript
Aug 12, 2021

$781.25 (-10.71%)

Earnings
Q1 2021 Trevena Inc Earnings Call Transcript
May 06, 2021

$1018.75 (-7.91%)

Earnings
Q4 2020 Trevena Inc Earnings Call Transcript
Mar 09, 2021

$1281.25

Earnings
Q3 2020 Trevena Inc Earnings Call Transcript
Nov 02, 2020

$1681.25 (+2.67%)

Earnings
Trevena Inc to Provide Update Following Recent FDA Approval of OLINVYK Transcript
Aug 10, 2020
Trevena Inc Annual Shareholders Meeting Transcript
May 13, 2020
Q1 2020 Trevena Inc Earnings Call Transcript
May 07, 2020

$579.75 (+2.91%)

Earnings
Q4 2019 Trevena Inc Earnings Call Transcript
Mar 12, 2020

$406.06 (-6.97%)

Earnings
Q3 2019 Trevena Inc Earnings Call Transcript
Nov 04, 2019

$512.5 (-17.42%)

Earnings
Q2 2019 Trevena Inc Earnings Call Transcript
Aug 07, 2019

$574.94 (+1.10%)

Earnings
Q1 2019 Trevena Inc Earnings Call Transcript
May 13, 2019

$881.25 (-10.76%)

Earnings
Q4 2018 Trevena Inc Earnings Call Transcript
Mar 13, 2019

$893.75 (-2.72%)

Earnings

Q1 2023 Trevena Inc Earnings Call Transcript

May 15, 2023 / 12:00PM GMT

Release Date Price: $29.5 (-12.59%)

Transcript 10-Q8-K8-K

Operator

Hello, and welcome to the Trevena, Inc. First Quarter 2023 Earnings Call. (Operator Instructions) Please note, today's event is being recorded.

I would now like to turn the conference over to Barry Shin, Chief Financial Officer. Please go ahead, sir.

Barry Shin

Trevena, Inc. - Senior VP & CFO

Thanks, Keith. Good morning, and welcome, everyone. With me today are Carrie Bourdow, our President and CEO; Patty Drake, our Chief Commercial Officer; and our Chief Medical Officer, Mark Demitrack.

As a reminder, OLINVYK was approved by the FDA in August 2020 and contains oliceridine, an opioid which is a Schedule II controlled substance with a high potential for abuse similar to other opioids. It's indicated in adults for the management of acute pain severe enough to require an IV opioid analgesic and for whom alternative treatments are inadequate. As with all opioids, serious, life-threatening or fatal respiratory depression may occur in patients treated with OLINVYK as indicated in the boxed warning. The important safety information, including

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.